$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Whether sotoracib (AMG 510) needs to be taken for life and the risk analysis of long-term use
2026-02-01 22:25:32
Check Details
How long does it usually take for adagrasib (Krazati) to take effect and the key factors affecting its efficacy
2026-02-01 22:25:32
Check Details
Analysis of clinical use effects and patient feedback of Pimitespib in Hainan Hospital
2026-02-01 22:25:32
Check Details
Detailed analysis of the instructions and medication guide for afatinib (Gitairin)
2026-02-01 22:25:32
Check Details
Daridorexant Tablets Purchase Channels and Price Reference Guide
2026-02-01 22:25:32
Check Details
Introduction to Olaparib manufacturer and original research information
2026-02-01 22:25:32
Check Details
Venetoclax latest market price and reference cost analysis
2026-02-01 22:25:32
Check Details
Detailed explanation of whether Asciminib/Asciminib has been included in medical insurance and reimbursement policy
2026-02-01 22:25:32
Check Details
Detailed explanation of the functions, efficacy and indications of ritexitinib (Lefenox)
2026-02-01 22:25:32
Check Details
Which company is Sparsentan developed by and what is the background of the drug?
2026-02-01 22:25:32
Check Details
Common side effects of ixazomib (Enleri) and patient medication safety guidance
2026-02-01 22:25:32
Check Details
Will rubitin/rubicatin (Zanbiga) withdraw from clinical trials for small cell lung cancer?
2026-02-01 22:25:32
Check Details
1
2
...
2102
2103
2104
2105
2106
2107
2108
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma